Empowering dialysis users and caregivers
Search for dialysis centres here
Log in to explore the world's most comprehensive database of dialysis centres for free!
Professional dialysis recruitment| Approval in US for Pfizer's renal cancer drug Inlyta - PMLiVE |
 |
 |
|
PMLiVE The US Food and Drug Administration (FDA) has approved Pfizer's Inlyta as a second-line treatment for patients with advanced renal cell carcinoma (RCC), a form of kidney cancer. On the same day, the FDA also started its review of Pfizer's bosutinib as |
